Potential Treatment for ROSAH Syndrome Accepted into FDA’s Rare Disease Evidence Principles Process Mar 12, 2026 | Autoimmune / Autoinflammatory Disorders +...

https://checkrare.com/ The US Food and Drug Administration (FDA) has accepted DF-003 into the FDA Rare Disease Evidence Principles Process (RDEP) for the potential treatment of ROSAH syndrome. ROSAH (retinal dystrophy,... AND MORE!!!